ibn-iw-globe-2.png
InvestorBrandNetwork Announces The Dealmaker Show Interview with Tryp Therapeutics Inc. CEO Greg McKee
August 03, 2021 08:00 ET | InvestorBrandNetwork (IBN)
LOS ANGELES, Aug. 03, 2021 (GLOBE NEWSWIRE) -- via InvestorWire – InvestorBrandNetwork (“IBN”), a multifaceted financial news and publishing company for private and public entities, today announces...
logo-dark.png
Aegis Sciences Announces CDC Contract to Provide Genomic Sequencing of SARS-CoV-2 to Aid Public Health Response to COVID-19
March 16, 2021 09:00 ET | Aegis Sciences Corporation
NASHVILLE, Tenn., March 16, 2021 (GLOBE NEWSWIRE) -- Aegis Sciences Corporation, a leading healthcare company that provides clinically innovative COVID-19 and medication compliance testing services,...
AIM ImmunoTech LOGO.jpg
AIM ImmunoTech to Present at the Q1 Virtual Investor Summit on March 24th
March 11, 2021 07:00 ET | AIM ImmunoTech Inc.
OCALA, Fla., March 11, 2021 (GLOBE NEWSWIRE) -- via InvestorWire – AIM ImmunoTech Inc. (NYSE American: AIM) today announced that Thomas K. Equels, Chief Executive Officer of AIM ImmunoTech, will be...
thumbnail_Pan-Biome-logo.png
Pan-Biome Pharmaceuticals, Inc reports positive results in preclinical trial of Inflammatory Bowel Disease: oral drug shows strong effect in modulating the gut microbiome
February 24, 2021 10:00 ET | Pan-Biome Pharmaceuticals, Inc
VANCOUVER, British Columbia, Feb. 24, 2021 (GLOBE NEWSWIRE) -- Pan-Biome Pharmaceuticals, Inc, a Vancouver based preclinical biopharmaceutical company focused on chronic inflammatory and autoimmune...
Sorman·Attali·Anholt “Seoul has shown 'Safe City' capabilities in the COVID-19 era” reports Republic of Korea news agency Newsis
October 29, 2020 10:55 ET | Newsis
Seoul City Hall, International Forum on 'Urban leadership in the Global Era' Guy Sorman "Seoul needs to be promoted as a 'safe city' to the world"Jacques Attali "Seoul has responded flexibly to...
provectus_logo.jpg
Provectus Biopharmaceuticals Announces Presentation of Preliminary Data from Combination Therapy Trial of PV-10® and KEYTRUDA® for Checkpoint-Refractory Advanced Cutaneous Melanoma at ESMO Virtual Congress 2020
September 17, 2020 07:00 ET | Provectus Biopharmaceuticals Inc.
36% ORR and 64% DCR (RECIST 1.1)PV-10-induced, tumor-specific restoration of T cell functionData compare favorably to approved and investigational therapies for patient population KNOXVILLE, TN,...
LSU CEE Professor Receives $1.5 Million Award for Oyster Research
August 25, 2020 11:36 ET | LSU College of Engineering
BATON ROUGE, La., Aug. 25, 2020 (GLOBE NEWSWIRE) -- Each year, nearly 2 billion oysters are consumed around the globe. The Gulf of Mexico produces more oysters than anywhere else in the United...
22157.jpg
Vaccines Witness Soaring Demand as Companies Strive to Contain the Coronavirus Outbreak - ResearchAndMarkets.com
April 08, 2020 07:20 ET | Research and Markets
DUBLIN, Ireland, April 08, 2020 (GLOBE NEWSWIRE) -- ResearchAndMarkets.com has identified Vaccines as one of the key sectors seeing growth opportunities during the Coronavirus pandemicDozens of...
22157.jpg
Telehealth Services Experience a Surge in Demand to Help Flatten the Curve of COVID-19 - ResearchAndMarkets.com
April 08, 2020 07:10 ET | Research and Markets
DUBLIN, Ireland, April 08, 2020 (GLOBE NEWSWIRE) -- ResearchAndMarkets.com identifies Telehealth as one of the industries experiencing increased demand during the Coronavirus pandemic During a...
22157.jpg
Global Personal Protective Equipment (PPE) Industry Witnessing Tremendous Demand Amid COVID-19 Pandemic - ResearchAndMarkets.com
April 08, 2020 07:03 ET | Research and Markets
DUBLIN, Ireland, April 08, 2020 (GLOBE NEWSWIRE) -- ResearchAndMarkets.com identifies Personal Protective Equipment as one of the industries experiencing increased demand during the Coronavirus...